What to do with hypertension and a murmur found during a preparticipation physical evaluation?

about

What to do with hypertension and a murmur found during a preparticipation physical evaluation?

Item

http://www.wikidata.org/entity/Q36093033

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

What to do with hypertension a ...... icipation physical evaluation?

@ast

What to do with hypertension a ...... icipation physical evaluation?

@en

type

Item

label

What to do with hypertension a ...... icipation physical evaluation?

@ast

What to do with hypertension a ...... icipation physical evaluation?

@en

prefLabel

What to do with hypertension a ...... icipation physical evaluation?

@ast

What to do with hypertension a ...... icipation physical evaluation?

@en

P1476

What to do with hypertension a ...... icipation physical evaluation?

@en

P2093

Angeline L Ong

http://www.w3.org/2001/XMLSchema#string

Daniel V Vigil

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American He

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes.

Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome.

Task Force 5: systemic hypertension.

Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.

Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.

P304

20-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7812/TPP/05-086

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22811640

http://www.w3.org/2001/XMLSchema#string

P932

3396098

http://www.w3.org/2001/XMLSchema#string